RU-486 safety profile
Executive Summary
FDA has "received a few letters about RU-486 expressing concerns about potential new safety risks," Commissioner McClellan says during National Press Club address Aug. 8. "We are carefully evaluating all of that information." The abortifacient is marketed by Danco as Mifeprex; the Bush Administration's theme since taking office has been that FDA will keep an eye on the safety of the drug as it would for any other marketed product (1"The Pink Sheet" Sept. 30, 2002, p. 6)...